Expression of epidermal growth factor receptor and transforming growth factor alpha in cancer bladder: Schistosomal and non-schistosomal

Bibliographic Information
Authors: Badawy A.A.; El-Hindawi A.; Hammam O.; Moussa M.; Helal N.S.; Kamel A.
Journal: Current Urology
Publisher: S. Karger AG
Publication Date: January 2017
Volume / Issue: Volume 9 / Issue 4
Pages: 192–201
ISSN: 16617649
DOI: 10.1159/000447140
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Badawy A.A., Department of Pathology, Theodor Bilharz Research Institute, El-Nile Street, Warrak El-Hadar, Imbaba, Giza, Egypt; El-Hindawi A., Department of Pathology, Faculty of Medicine, Cairo University, Giza, Egypt; Hammam O., Department of Pathology, Theodor Bilharz Research Institute, El-Nile Street, Warrak El-Hadar, Imbaba, Giza, Egypt; Moussa M., Department of Pathology, Theodor Bilharz Research Institute, El-Nile Street, Warrak El-Hadar, Imbaba, Giza, Egypt; Helal N.S., Department of Pathology, Theodor Bilharz Research Institute, El-Nile Street, Warrak El-Hadar, Imbaba, Giza, Egypt; Kamel A., Department of Pathology, Theodor Bilharz Research Institute, El-Nile Street, Warrak El-Hadar, Imbaba, Giza, Egypt
Abstract
Introduction: Overexpression of epidermal growth factor receptor (EGFR) has been described in several solid tumors including bladder cancer. Transforming growth factor alpha (TGFα) is frequently deregulated in neoplastic cells and plays a role in the development of bladder cancer. TGFα-EGFR ligand-receptor combination constitutes an important event in multistep tumorigenesis. Methods: This study was done on 30 bladder biopsies from patients with urothelial carcinoma, 15 with squamous cell carcinoma, 10 with cystitis and 5 normal control bladder specimens. All were immuohistochemically stained with EGFR and TGFα antibodies. Results: EGFR and TGFα were over-expressed in higher grades and late stages of bladder cancer. Moreover, they show higher expression in squamous cell carcinoma compared to urothelial carcinoma and in schistosomal associated lesions than in non-schistosomal associated lesions. Conclusion: EGFR and TGFα could be used as prognostic predictors in early stage and grade of bladder cancer cases, especially those with schistosomal association. In addition they can help in selecting patients who can get benefit from anti-EGFR molecular targeted therapy. © 2015 S. Karger AG, Basel.
Keywords
Bladder cancer; Epidermal growth factor receptor; Immunohistochemistry; Schistosomiasis; Transforming growth factor-α; transforming growth factor alpha; adult; aged; Article; bladder biopsy; cancer grading; cancer staging; carcinogenesis; controlled study; cystitis; disease association; female; histopathology; human; human tissue; major clinical study; male; muscle invasive bladder cancer; priority journal; protein expression; Schistosoma; schistosomal carcinoma; schistosomal cystitis; scoring system; squamous cell carcinoma; transitional cell carcinoma
Citation Information
Scopus Citations: 10
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
